ConductScience.org, home

Paper41588902

An Overview of the Antioxidant, Anti-inflammatory, and Anticancer Effects of Statins.

Zarei F and 4 others. Anticancer Agents Med Chem, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. An Overview of the Antioxidant, Anti-inflammatory, and Anticancer Effects of Statins. Papers, record 41588902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41588902

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An Overview of the Antioxidant, Anti-inflammatory, and Anticancer Effects of Statins.
PubMed
Journal
Anticancer Agents Med Chem
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-06-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zarei FFatemehhttps://orcid.org/0000-0003-0382-4518
2Salimi ZZahra
3Zeinivand MMotahareh
4Zamani NNastaran
5Bahrani RReza

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydroxymethylglutaryl-CoA Reductase InhibitorsMajor topic
AntioxidantsMajor topic
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Anti-Inflammatory AgentsMajor topic
Anti-Inflammatory Agents, Non-SteroidalMajor topic
Humans
Animals
Cell Proliferation
Drug Screening Assays, Antitumor
Oxidative Stress

Source PubMed

Download CSV of topics

References182

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121067804Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.Lancet2010https://conductscience.org/library/papers/21067804PubMed
2791911Citrinin, an inhibitor of cholesterol synthesis.J Antibiot (Tokyo)1976https://conductscience.org/library/papers/791911PubMed
36933445Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6933445PubMed
417928595Long-term follow-up of the West of Scotland Coronary Prevention Study.N Engl J Med2007https://conductscience.org/library/papers/17928595PubMed
515325833Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.Lancet2004https://conductscience.org/library/papers/15325833PubMed
611306519Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.Circulation2001https://conductscience.org/library/papers/11306519PubMed
711145942Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering.Arterioscler Thromb Vasc Biol2001https://conductscience.org/library/papers/11145942PubMed
815645009Antioxidant effects of statins.Drugs Today (Barc)2004https://conductscience.org/library/papers/15645009PubMed
923924053Differential metabolic actions of specific statins: clinical and therapeutic considerations.Antioxid Redox Signal2014https://conductscience.org/library/papers/23924053PubMed
1016054715Effects of statins beyond lipid lowering: potential for clinical benefits.Int J Cardiol2006https://conductscience.org/library/papers/16054715PubMed
1124854145Atorvastatin improves survival of implanted stem cells in a rat model of renal ischemia-reperfusion injury.Am J Nephrol2014https://conductscience.org/library/papers/24854145PubMed
1227035900Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.Curr Opin Neurol2016https://conductscience.org/library/papers/27035900PubMed
1321207250Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial.Lipids2011https://conductscience.org/library/papers/21207250PubMed
1428721151Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot study.Arch Med Sci2017https://conductscience.org/library/papers/28721151PubMed
1524127541The role of oxidative stress during inflammatory processes.Biol Chem2014https://conductscience.org/library/papers/24127541PubMed
1628969555Oxidative Stress and Cancer: The Role of Nrf2.Curr Cancer Drug Targets2018https://conductscience.org/library/papers/28969555PubMed
1711932263Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond.J Clin Endocrinol Metab2002https://conductscience.org/library/papers/11932263PubMed
1816126020Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.Am J Cardiol2005https://conductscience.org/library/papers/16126020PubMed
1929363784Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience.Clin Cardiol2018https://conductscience.org/library/papers/29363784PubMed
2012011277Statins and risk of polyneuropathy: a case-control study.Neurology2002https://conductscience.org/library/papers/12011277PubMed

See all 182 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42953363New strategies for the treatment of tuberculosis: research progress and clinical translation in immune modulation and inflammation control.Front Immunol2026https://conductscience.org/library/papers/42953363PubMed
42746176Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis.Front Immunol2026https://conductscience.org/library/papers/42746176PubMed
42215843Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options.Mol Biomed2026https://conductscience.org/library/papers/42215843PubMed
42074763Statins and Fibrates in Age-Related Macular Degeneration: A Contemporary Clinical Narrative Review (2020-2025).J Clin Med2026https://conductscience.org/library/papers/42074763PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BDNF627PubTator's text mininghttps://conductscience.org/library/genes/627NCBI Gene
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41588902

GET https://conductscience.org/api/papers/v1/41588902/references?page=2